drugset / Trial / NCT06782529

Knee Injections for Obese Patients With Knee Arthritis

NCT06782529

Phase 4 Recruiting 40 enrolled Mayo Clinic
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

Timeline

Start
2025-01-24
Primary completion
2027-01-24
Completion
2027-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 20 mg Other
Subject Triamcinolone Acetonide Other / unclassified 40 mg Other

Indications